More scientific evidence is emerging to show that our gastrointestinal system interacts with our nervous system ...

GLP-1 receptor agonists such as semaglutide and liraglutide promote significant weight loss and improved glycemic control, ...

Regarding injection site rotation, alternate between different areas like the abdomen, thigh, or upper arm to prevent ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

Introduction Sodium-glucose cotransporter 2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) are two classes of glucose-lowering drugs gaining popularity in the treatment ...

As weight loss jabs like Ozempic and Wegovy become ever more popular, doctors are growing increasingly concerned about their gnarly side effects. As Germany's Deutsche Welle notes, people who take ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

SGLT2 inhibitors and GLP-1 receptor agonists lower cardiovascular risk in type 2 diabetes, but a recent review suggests that ...

GLP-1 RAs are associated with a modestly increased risk for GERD and gallstone disease but not with GI and biliary complications.

Some weight loss drugs may cause hair loss. While it’s typically a temporary side effect, it can affect your confidence.

GLP-1RAs were associated with improved quality of life and emotional eating behaviors among individuals with overweight and obesity.

GLP-1 drugs alter taste perceptions, challenging food makers to adapt by enhancing umami flavours, balancing sweetness, and ...